Company Filing History:
1 out of 7 
1 out of 5,094 
1 out of 1,745 
Years Active: 2025
Title: Christine Balducci: Innovator in Eye Disease Treatment
Introduction
Christine Balducci is a notable inventor based in Saint Germain Les Arpajon, France. She has made significant contributions to the field of ophthalmology through her innovative research and development of chemical compounds aimed at treating eye diseases. Her work focuses on addressing critical conditions such as age-related macular degeneration and Stargardt's disease.
Latest Patents
Christine Balducci holds a patent for chemical compounds targeting the eye. This patent, which is a significant advancement in the treatment of eye diseases, discloses chemical compounds C that are derivatives of norbixin. These compounds have a specific tropism for the eye and are intended for use in altering the retinal pigment epithelium, particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease. She has 1 patent to her name.
Career Highlights
Throughout her career, Christine has worked with prominent organizations, including Biophytis and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to develop her expertise in the field of eye health and contribute to groundbreaking research.
Collaborations
Christine has collaborated with esteemed colleagues, including Laurence Dinan and René Lafont. These partnerships have further enriched her research and innovation efforts in the treatment of eye diseases.
Conclusion
Christine Balducci's work in developing chemical compounds for eye disease treatment showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against debilitating eye conditions.